NCT07126665View on ClinicalTrials.gov

A Study of MHB088C Combined With MHB039A in Patients With Advanced Malignant Solid Tumors

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

August 31, 2029

Study Completion Date

August 31, 2031

Conditions
Advanced Malignant Solid Tumor
Interventions
DRUG

MHB088C for Injection

Intravenous administration

DRUG

MHB039A for Injection

Intravenous administration

Sponsors
All Listed Sponsors
lead

Minghui Pharmaceutical (Hangzhou) Ltd

INDUSTRY

NCT07126665 - A Study of MHB088C Combined With MHB039A in Patients With Advanced Malignant Solid Tumors | Biotech Hunter | Biotech Hunter